Mary-Lee DEQUÉANT

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods and compositions for treating cancer
- Patent number 12,227,763
- Issue date Feb 18, 2025
- CRISPR THERAPEUTICS AG
- Jonathan Alexander Terrett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Genetically engineered T cells with Regnase-1 and/or TGFBRII disrup...
- Patent number 11,857,574
- Issue date Jan 2, 2024
- CRISPR THERAPEUTICS AG
- Mary-Lee Dequeant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-idiotype antibodies targeting anti-CD70 chimeric antigen receptor
- Patent number 11,795,238
- Issue date Oct 24, 2023
- CRISPR THERAPEUTICS AG
- Lalit Kumar
- G01 - MEASURING TESTING
Information Patent Grant
Genetically engineered t cells with Regnase-1 and/or TGFBRII disrup...
- Patent number 11,679,130
- Issue date Jun 20, 2023
- CRISPR THERAPEUTICS AG
- Mary-Lee Dequeant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Genetically engineered T cells with regnase-1 and/or TGFBRII disrup...
- Patent number 11,679,131
- Issue date Jun 20, 2023
- CRISPR THERAPEUTICS AG
- Mary-Lee Dequeant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for treating cancer
- Patent number 11,649,438
- Issue date May 16, 2023
- CRISPR THERAPEUTICS AG
- Jonathan Alexander Terrett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Genetically engineered t cells with regnase-1 and/or TGFBRII disrup...
- Patent number 11,497,773
- Issue date Nov 15, 2022
- CRISPR THERAPEUTICS AG
- Mary-Lee Dequeant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for treating cancer
- Patent number 11,254,912
- Issue date Feb 22, 2022
- CRISPR THERAPEUTICS AG
- Jonathan Alexander Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUP...
- Publication number 20250179146
- Publication date Jun 5, 2025
- CRISPR Therapeutics AG
- Mary-Lee Dequeant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODULATING EXPRESSION OF ALAS1 (5'-AMINOLEVULINATE SYNTHASE 1) GENE
- Publication number 20250027087
- Publication date Jan 23, 2025
- CRISPR Therapeutics AG
- Mary-Lee Dequeant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CD70+ SOLID TUMOR THERAPY USING GENETICALLY ENGINEERED T CELLS TARG...
- Publication number 20230355761
- Publication date Nov 9, 2023
- CRISPR Therapeutics AG
- Jonathan Alexander TERRETT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD19 CAR-T CELLS WITH MULTIPLE GENE EDITS AND THERAPEUTIC USES...
- Publication number 20230303713
- Publication date Sep 28, 2023
- CRISPR Therapeutics AG
- Mohammed Ghonime
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUP...
- Publication number 20230263828
- Publication date Aug 24, 2023
- CRISPR Therapeutics AG
- Mary-Lee Dequeant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR MANUFACTURING GENETICALLY ENGINEERED CAR-T CELLS
- Publication number 20230046228
- Publication date Feb 16, 2023
- CRISPR Therapeutics AG
- Hui YU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RENAL CELL CARCINOMA (RCC) THERAPY USING GENETICALLY ENGINEERED T C...
- Publication number 20220387572
- Publication date Dec 8, 2022
- CRISPR Therapeutics AG
- Jonathan Alexander TERRETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THERAPY FOR HEMATOPOIETIC CELL MALIGNANCIES USING GENETICALLY ENGIN...
- Publication number 20220387571
- Publication date Dec 8, 2022
- CRISPR THERAPEUTICS AG
- Jonathan Alexander TERRETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETICALLY ENGINEERED IMMUNE CELLS TARGETING CD70 FOR USE IN TREAT...
- Publication number 20220387488
- Publication date Dec 8, 2022
- CRISPR Therapeutics AG
- Jonathan Alexander TERRETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETICALLY ENGINEERED IMMUNE CELLS TARGETING CD70 FOR USE IN TREAT...
- Publication number 20220378829
- Publication date Dec 1, 2022
- CRISPR Therapeutics AG
- Jonathan Alexander TERRETT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUP...
- Publication number 20220088077
- Publication date Mar 24, 2022
- CRISPR Therapeutics AG
- Mary-Lee Dequeant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUP...
- Publication number 20220088078
- Publication date Mar 24, 2022
- CRISPR Therapeutics AG
- Mary-Lee Dequeant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUP...
- Publication number 20220090012
- Publication date Mar 24, 2022
- CRISPR Therapeutics AG
- Mary-Lee Dequeant
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-IDIOTYPE ANTIBODIES TARGETING ANTI-CD70 CHIMERIC ANTIGEN RECEPTOR
- Publication number 20220041754
- Publication date Feb 10, 2022
- CRISPR Therapeutics AG
- Lalit KUMAR
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUP...
- Publication number 20220016173
- Publication date Jan 20, 2022
- CRISPR Therapeutics AG
- Mary-Lee Dequeant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING CANCER
- Publication number 20210261919
- Publication date Aug 26, 2021
- CRISPR Therapeutics AG
- Jonathan Alexander TERRETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING CANCER
- Publication number 20210246425
- Publication date Aug 12, 2021
- CRISPR Therapeutics AG
- Jonathan Alexander TERRETT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING CANCER
- Publication number 20210060072
- Publication date Mar 4, 2021
- CRISPR Therapeutics AG
- Jonathan Alexander TERRETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING CANCER
- Publication number 20200063100
- Publication date Feb 27, 2020
- CRISPR Therapeutics AG
- Jonathan Alexander TERRETT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Mary-Lee DEQUÉANT

Person

Patents Grantslast 30 patents

Methods and compositions for treating cancer

Genetically engineered T cells with Regnase-1 and/or TGFBRII disrup...

Anti-idiotype antibodies targeting anti-CD70 chimeric antigen receptor

Genetically engineered t cells with Regnase-1 and/or TGFBRII disrup...

Genetically engineered T cells with regnase-1 and/or TGFBRII disrup...

Methods and compositions for treating cancer

Genetically engineered t cells with regnase-1 and/or TGFBRII disrup...

Methods and compositions for treating cancer

Patents Applicationslast 30 patents

GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUP...

MODULATING EXPRESSION OF ALAS1 (5'-AMINOLEVULINATE SYNTHASE 1) GENE

CD70+ SOLID TUMOR THERAPY USING GENETICALLY ENGINEERED T CELLS TARG...

ANTI-CD19 CAR-T CELLS WITH MULTIPLE GENE EDITS AND THERAPEUTIC USES...

GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUP...

METHODS FOR MANUFACTURING GENETICALLY ENGINEERED CAR-T CELLS

RENAL CELL CARCINOMA (RCC) THERAPY USING GENETICALLY ENGINEERED T C...

THERAPY FOR HEMATOPOIETIC CELL MALIGNANCIES USING GENETICALLY ENGIN...

GENETICALLY ENGINEERED IMMUNE CELLS TARGETING CD70 FOR USE IN TREAT...

GENETICALLY ENGINEERED IMMUNE CELLS TARGETING CD70 FOR USE IN TREAT...

GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUP...

GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUP...

GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUP...

ANTI-IDIOTYPE ANTIBODIES TARGETING ANTI-CD70 CHIMERIC ANTIGEN RECEPTOR

GENETICALLY ENGINEERED T CELLS WITH REGNASE-1 AND/OR TGFBRII DISRUP...

METHODS AND COMPOSITIONS FOR TREATING CANCER

METHODS AND COMPOSITIONS FOR TREATING CANCER

METHODS AND COMPOSITIONS FOR TREATING CANCER

METHODS AND COMPOSITIONS FOR TREATING CANCER